|
60 Degrees Pharmaceuticals Inc
|
SXTP |
US |
0,50 |
USD |
-87,8 % |
2026-11-17 |
|
Aardvark Therapeutics Inc
|
AARD |
US |
1,26 |
USD |
-87,2 % |
2026-11-16 |
|
Abbott Laboratories
|
ABT |
US |
107,45 |
USD |
-17,3 % |
2026-11-16 |
|
AbbVie Inc
|
ABBV |
US |
294,55 |
USD |
+25,9 % |
2026-11-16 |
|
Abcellera Biologics Inc
|
ABCL |
CA |
11,12 |
USD |
+203,8 % |
2026-11-16 |
|
Abeona Therapeutics Inc
|
ABEO |
US |
2,60 |
USD |
-42,0 % |
2026-11-16 |
|
Abivax SA
|
ABVX |
FR |
83,61 |
EUR |
-26,5 % |
2026-11-16 |
|
ABVC Biopharma Inc
|
ABVC |
US |
0,94 |
USD |
-67,8 % |
2026-11-16 |
|
AC Immune SA
|
ACIU |
CH |
2,09 |
CHF |
-31,5 % |
2026-11-16 |
|
ACADIA Pharmaceuticals Inc
|
ACAD |
US |
18,67 |
USD |
-21,6 % |
2026-11-16 |
|
Aclaris Therapeutics Inc
|
ACRS |
US |
3,61 |
USD |
+44,8 % |
2026-11-16 |
|
Acrivon Therapeutics Inc
|
ACRV |
US |
1,46 |
USD |
-39,9 % |
2026-11-16 |
|
Actinium Pharmaceuticals Inc
|
ATNM |
US |
1,35 |
USD |
-5,6 % |
2026-11-17 |
|
Actuate Therapeutics Inc
|
ACTU |
US |
0,27 |
USD |
-95,6 % |
2026-11-16 |
|
Adagene Inc
|
ADAG |
CN |
1,60 |
USD |
-19,3 % |
2026-11-16 |
|
ADC Therapeutics SA
|
ADCT |
CH |
1,25 |
USD |
-68,8 % |
2026-11-16 |
|
Adial Pharmaceuticals Inc
|
ADIL |
US |
4,05 |
USD |
-47,7 % |
2026-11-04 |
|
Adicet Bio Inc
|
ACET |
US |
2,75 |
USD |
-71,4 % |
2026-11-16 |
|
Aditxt Inc
|
ADTX |
US |
0,00 |
USD |
-100,0 % |
2026-11-16 |
|
Agios Pharmaceuticals Inc
|
AGIO |
US |
30,15 |
USD |
-33,7 % |
2026-11-16 |
|
Akebia Therapeutics Inc
|
AKBA |
US |
0,45 |
USD |
-72,8 % |
2026-11-16 |
|
Aktis Oncology Inc
|
AKTS |
US |
16,21 |
USD |
— |
2026-11-17 |
|
Alaunos Therapeutics Inc
|
TCRT |
US |
1,55 |
USD |
-53,6 % |
2026-11-17 |
|
Aldeyra Therapeutics Inc
|
ALDX |
US |
0,67 |
USD |
-86,4 % |
2026-11-16 |
|
Alkermes Plc
|
ALKS |
IE |
46,53 |
USD |
+59,0 % |
2026-11-16 |
|
Allarity Therapeutics Inc
|
ALLR |
US |
0,88 |
USD |
-23,2 % |
2026-11-16 |
|
Alnylam Pharmaceuticals Inc
|
ALNY |
US |
159,73 |
USD |
-65,4 % |
2026-11-16 |
|
Altimmune Inc
|
ALT |
US |
1,56 |
USD |
-66,5 % |
2026-11-16 |
|
Alto Neuroscience Inc
|
ANRO |
US |
24,91 |
USD |
+68,9 % |
2026-11-17 |
|
Alumis Inc
|
ALMS |
US |
5,14 |
USD |
-19,8 % |
2026-11-16 |
|
ALX Oncology Holdings Inc
|
ALXO |
US |
1,00 |
USD |
-38,7 % |
2026-11-16 |
|
Amarin Corporation PLC
|
AMRN |
IE |
11,31 |
USD |
-32,3 % |
2026-11-16 |
|
Amneal Pharmaceuticals Inc
|
AMRX |
US |
21,23 |
USD |
+83,5 % |
2026-11-16 |
|
Amphastar Pharmaceuticals Inc
|
AMPH |
US |
29,17 |
USD |
+12,6 % |
2026-11-16 |
|
Amylyx Pharmaceuticals Inc
|
AMLX |
US |
27,80 |
USD |
+99,3 % |
2026-11-16 |
|
AN2 Therapeutics Inc
|
ANTX |
US |
4,23 |
USD |
+277,7 % |
2026-11-17 |
|
AnaptysBio Inc
|
ANAB |
US |
45,61 |
USD |
+84,9 % |
2026-11-17 |
|
ANI Pharmaceuticals Inc
|
ANIP |
US |
69,99 |
USD |
-13,7 % |
2026-11-17 |
|
Anixa Biosciences Inc
|
ANIX |
US |
2,67 |
USD |
-34,9 % |
2026-11-17 |
|
Annexon Inc
|
ANNX |
US |
3,47 |
USD |
+8,4 % |
2026-11-17 |
|
Annovis Bio Inc
|
ANVS |
US |
0,74 |
USD |
-78,0 % |
2026-11-17 |
|
Apollomics Inc
|
APLM |
US |
16,84 |
USD |
-8,2 % |
2026-11-17 |
|
Aptevo Therapeutics Inc
|
APVO |
US |
0,46 |
USD |
-98,1 % |
2026-11-17 |
|
Aquestive Therapeutics Inc
|
AQST |
US |
3,70 |
USD |
-37,4 % |
2026-11-17 |
|
Arbutus Biopharma Corp
|
ABUS |
US |
4,04 |
USD |
-9,2 % |
2026-11-16 |
|
Arcturus Therapeutics Holdings Inc
|
ARCT |
US |
7,97 |
USD |
+20,4 % |
2026-11-17 |
|
Arcus Biosciences Inc
|
RCUS |
US |
16,36 |
USD |
-19,0 % |
2026-11-17 |
|
Arcutis Biotherapeutics Inc
|
ARQT |
US |
27,33 |
USD |
+0,2 % |
2026-11-17 |
|
Ardelyx Inc
|
ARDX |
US |
3,18 |
USD |
-45,3 % |
2026-11-17 |
|
ArriVent BioPharma Inc
|
AVBP |
US |
10,69 |
USD |
-47,1 % |
2026-11-17 |
|
Arrowhead Pharmaceuticals Inc
|
ARWR |
US |
42,99 |
USD |
+6,2 % |
2026-11-17 |
|
ARS Pharmaceuticals Inc
|
SPRY |
US |
3,70 |
USD |
-47,8 % |
2026-11-17 |
|
Artelo Biosciences Inc
|
ARTL |
US |
1,68 |
USD |
-96,7 % |
2026-11-17 |
|
Arvinas Inc
|
ARVN |
US |
6,82 |
USD |
-47,5 % |
2026-11-17 |
|
Ascendis Pharma A/S
|
ASND |
DK |
271,19 |
EUR |
+24,9 % |
2026-11-17 |
|
Ascentage Pharma Group International
|
AAPG |
CN |
13,29 |
CNY |
-58,5 % |
2026-11-16 |
|
Aspire Biopharma Holdings Inc
|
ASBP |
PR |
8,30 |
USD |
+95,8 % |
2026-11-17 |
|
Assembly Biosciences Inc
|
ASMB |
US |
22,50 |
USD |
-37,3 % |
2026-11-17 |
|
Assertio Holdings Inc
|
ASRT |
US |
23,50 |
USD |
— |
2026-06-29 |
|
AstraZeneca PLC
|
AZN |
GB |
182,27 |
USD |
+1,8 % |
2026-11-17 |
|
Atai Beckley NV
|
ATAI |
NL |
7,35 |
USD |
+87,0 % |
2026-09-11 |
|
Atea Pharmaceuticals Inc
|
AVIR |
US |
3,96 |
USD |
+29,8 % |
2026-11-17 |
|
Atossa Therapeutics Inc
|
ATOS |
US |
1,90 |
USD |
-84,0 % |
2026-11-17 |
|
Aurinia Pharmaceuticals Inc
|
AUPH |
CA |
15,40 |
USD |
-0,6 % |
2026-11-17 |
|
Aurora Cannabis Inc
|
ACB |
CA |
4,61 |
CAD |
+4,1 % |
2026-11-16 |
|
Avalo Therapeutics Inc
|
AVTX |
US |
7,13 |
USD |
-60,4 % |
2026-11-17 |
|
Axsome Therapeutics Inc
|
AXSM |
US |
135,95 |
USD |
-7,8 % |
2026-11-17 |
|
Bausch Health Companies Inc
|
BHC |
CA |
8,47 |
USD |
+37,1 % |
2026-11-17 |
|
Belite Bio Inc
|
BLTE |
US |
157,72 |
USD |
+28,0 % |
2026-11-17 |
|
Benitec Biopharma Inc
|
BNTC |
US |
8,15 |
USD |
-39,8 % |
2026-11-17 |
|
BGM Group Ltd
|
BGM |
CN |
8,13 |
USD |
-97,0 % |
2026-11-17 |
|
Bicara Therapeutics Inc
|
BCAX |
US |
9,60 |
USD |
-38,3 % |
2026-11-17 |
|
Bicycle Therapeutics PLC
|
BCYC |
GB |
3,20 |
USD |
-50,5 % |
2026-11-17 |
|
BIOAGE Labs Inc
|
BIOA |
US |
5,10 |
USD |
-38,2 % |
2026-11-17 |
|
Biodexa Pharmaceuticals PLC
|
BDRX |
GB |
2,14 |
GBP |
-90,7 % |
2026-11-17 |
|
Biohaven Ltd
|
BHVN |
US |
13,24 |
USD |
+40,1 % |
2026-11-17 |
|
BioLine RX Ltd
|
BLRX |
IL |
1,12 |
USD |
-65,1 % |
2026-11-17 |
|
BioMarin Pharmaceutical Inc
|
BMRN |
US |
58,51 |
USD |
+8,0 % |
2026-11-17 |
|
Biomea Fusion Inc
|
BMEA |
US |
0,49 |
USD |
-58,6 % |
2026-11-17 |
|
Biote Corp
|
BTMD |
US |
0,99 |
USD |
-60,2 % |
2026-11-17 |
|
BioVie Inc
|
BIVI |
US |
1,00 |
USD |
-30,4 % |
2026-11-17 |
|
BioXcel Therapeutics Inc
|
BTAI |
US |
0,05 |
USD |
-97,4 % |
2026-10-08 |
|
Bolt Biotherapeutics Inc
|
BOLT |
US |
5,65 |
USD |
+22,4 % |
2026-11-17 |
|
Bon Natural Life Ltd
|
BON |
CN |
1,07 |
USD |
-33,5 % |
2026-11-17 |
|
Boundless Bio Inc
|
BOLD |
US |
2,41 |
USD |
+102,5 % |
2026-11-17 |
|
BridgeBio Oncology Therapeutics Inc
|
BBOT.US |
— |
1,94 |
USD |
-85,6 % |
2026-11-17 |
|
BridgeBio Pharma Inc
|
BBIO |
US |
76,80 |
USD |
+17,1 % |
2026-11-17 |
|
Bright Minds Biosciences Inc
|
DRUG |
US |
20,51 |
CAD |
-64,5 % |
2026-11-17 |
|
Bristol-Myers Squibb Co
|
BMY |
US |
61,35 |
USD |
+30,4 % |
2026-11-17 |
|
Bullfrog AI Holdings Inc
|
BFRG |
US |
0,41 |
USD |
-55,7 % |
2026-11-17 |
|
Cadrenal Therapeutics Inc
|
CVKD |
US |
1,88 |
USD |
-84,2 % |
2026-11-17 |
|
Canopy Growth Corp
|
CGC |
CA |
0,53 |
CAD |
-50,4 % |
2026-11-17 |
|
Capricor Therapeutics Inc
|
CAPR |
US |
8,41 |
USD |
+49,1 % |
2026-11-17 |
|
Cartesian Therapeutics Inc
|
RNAC |
US |
6,06 |
USD |
-20,5 % |
2026-11-17 |
|
CDT Equity Inc
|
CDT |
US |
0,36 |
USD |
-100,0 % |
2026-11-17 |
|
Cellectar Biosciences Inc
|
CLRB |
US |
0,92 |
USD |
-70,0 % |
2026-11-17 |
|
Celularity Inc
|
CELU |
US |
0,57 |
USD |
-67,2 % |
2026-11-17 |
|
Centessa Pharmaceuticals PLC
|
CNTA |
GB |
— |
USD |
— |
|
|
CervoMed Inc
|
CRVO |
US |
1,50 |
USD |
-81,9 % |
2026-11-17 |
|
Chemomab Therapeutics Ltd
|
CMMB |
IL |
1,62 |
USD |
-40,7 % |
2026-11-16 |
|
China SXT Pharmaceuticals Inc
|
SXTC |
CN |
2,85 |
USD |
-100,0 % |
2026-11-17 |
|
Cingulate Inc
|
CING |
US |
4,72 |
USD |
+39,6 % |
2026-11-17 |
|
Citius Oncology Inc
|
CTOR |
US |
0,55 |
USD |
-57,2 % |
2026-11-17 |
|
Citius Pharmaceuticals Inc
|
CTXR |
US |
0,52 |
USD |
-51,5 % |
2026-11-17 |
|
Clearmind Medicine Inc
|
CMND |
CA |
4,18 |
USD |
-95,2 % |
2026-11-16 |
|
Clene Inc
|
CLNN |
US |
3,22 |
USD |
-62,4 % |
2026-11-17 |
|
Climb Bio Inc
|
CLYM |
US |
9,94 |
USD |
+420,4 % |
2026-11-16 |
|
CLOSE ONLY / Celsion Corp
|
CLSN.US |
— |
— |
USD |
— |
|
|
CLOSE ONLY / Homology Medicines Inc
|
FIXX |
BR |
105,78 |
BRL |
— |
2026-11-17 |
|
CLOSE ONLY / Indivior PLC
|
INDV.UK |
— |
— |
GBP |
— |
|
|
CNS Pharmaceuticals Inc
|
CNSP |
US |
4,15 |
USD |
-38,3 % |
2026-11-17 |
|
Cogent Biosciences Inc
|
COGT |
US |
27,85 |
USD |
-16,6 % |
2026-11-17 |
|
Collegium Pharmaceutical Inc
|
COLL |
US |
25,55 |
USD |
-43,6 % |
2026-11-17 |
|
Compass Pathways PLC
|
CMPS |
GB |
8,27 |
USD |
+53,4 % |
2026-11-16 |
|
Connect Biopharma Holdings Ltd
|
CNTB |
US |
0,58 |
USD |
-77,5 % |
2026-11-17 |
|
Context Therapeutics Inc
|
CNTX |
US |
0,17 |
USD |
-84,2 % |
2026-11-17 |
|
Contineum Therapeutics Inc
|
CTNM |
US |
9,55 |
USD |
-17,0 % |
2026-11-17 |
|
Corbus Pharmaceuticals Holdings Inc
|
CRBP |
US |
3,01 |
USD |
-74,9 % |
2026-11-17 |
|
Corcept Therapeutics Inc
|
CORT |
US |
70,07 |
USD |
-6,7 % |
2026-11-17 |
|
CorMedix Inc
|
CRMD |
US |
4,67 |
USD |
-53,7 % |
2026-11-17 |
|
Corvus Pharmaceuticals Inc
|
CRVS |
US |
10,17 |
USD |
+11,9 % |
2026-11-17 |
|
Coya Therapeutics Inc
|
COYA |
US |
3,02 |
USD |
-51,0 % |
2026-11-17 |
|
Crinetics Pharmaceuticals Inc
|
CRNX |
US |
84,95 |
USD |
+97,5 % |
2026-09-02 |
|
Cronos Group Inc
|
CRON |
CA |
3,19 |
USD |
+30,7 % |
2026-11-17 |
|
Cryoport Inc
|
CYRX |
US |
19,74 |
USD |
+135,3 % |
2026-11-17 |
|
Cue Biopharma Inc
|
CUE |
US |
2,83 |
USD |
-83,7 % |
2026-11-17 |
|
Cumberland Pharmaceuticals Inc
|
CPIX |
US |
5,80 |
USD |
+194,4 % |
2026-11-17 |
|
Cytokinetics Inc
|
CYTK |
US |
51,65 |
USD |
-21,9 % |
2026-11-17 |
|
CytoMed Therapeutics Ltd
|
GDTC |
SG |
0,78 |
SGD |
-60,3 % |
2026-11-17 |
|
CytomX Therapeutics Inc
|
CTMX |
US |
1,94 |
USD |
-47,0 % |
2026-11-17 |
|
Dare Bioscience Inc
|
DARE |
US |
0,43 |
USD |
-75,9 % |
2026-11-17 |
|
Definium Therapeutics Inc
|
DFTX.US |
— |
29,38 |
USD |
+157,5 % |
2026-11-17 |
|
Dermata Therapeutics Inc
|
DRMA |
US |
0,57 |
USD |
-78,7 % |
2026-11-17 |
|
Design Therapeutics Inc
|
DSGN |
US |
9,84 |
USD |
+29,6 % |
2026-11-17 |
|
DiaMedica Therapeutics Inc
|
DMAC |
US |
8,38 |
USD |
+21,4 % |
2026-11-17 |
|
Dianthus Therapeutics Inc
|
DNTH |
US |
86,98 |
USD |
+113,1 % |
2026-11-17 |
|
Disc Medicine Inc
|
IRON |
US |
76,57 |
USD |
-14,7 % |
2026-11-17 |
|
Dogwood Therapeutics Inc
|
DWTX |
US |
1,08 |
USD |
-82,4 % |
2026-11-17 |
|
Dr Reddy's Laboratories Ltd
|
RDY |
IN |
14,86 |
INR |
+6,0 % |
2026-11-17 |
|
Dyne Therapeutics Inc
|
DYN |
US |
16,02 |
USD |
-23,6 % |
2026-11-17 |
|
Edgewise Therapeutics Inc
|
EWTX |
US |
42,04 |
USD |
+89,7 % |
2026-11-17 |
|
Elanco Animal Health Inc
|
ELAN |
US |
25,85 |
USD |
+20,9 % |
2026-11-17 |
|
Eledon Pharmaceuticals Inc
|
ELDN |
US |
1,98 |
USD |
+28,6 % |
2026-11-17 |
|
Eli Lilly and Co
|
LLY |
US |
1 429,16 |
USD |
+38,7 % |
2026-11-17 |
|
Eli Lilly and Co
|
LLY.DE |
— |
1 301,00 |
EUR |
+45,6 % |
2026-11-17 |
|
Elicio Therapeutics Inc
|
ELTX |
US |
1,43 |
USD |
-83,3 % |
2026-11-17 |
|
Emergent BioSolutions Inc
|
EBS |
US |
5,61 |
USD |
-44,6 % |
2026-11-17 |
|
Enanta Pharmaceuticals Inc
|
ENTA |
US |
8,69 |
USD |
-29,7 % |
2026-11-17 |
|
Enliven Therapeutics Inc
|
ELVN |
US |
46,85 |
USD |
+107,4 % |
2026-11-17 |
|
Enlivex Therapeutics Ltd
|
ENLV |
IL |
1,15 |
USD |
-92,2 % |
2026-11-17 |
|
Ensysce Biosciences Inc
|
ENSC |
US |
0,38 |
USD |
-80,1 % |
2026-11-17 |
|
Entrada Therapeutics Inc
|
TRDA |
US |
5,28 |
USD |
-40,1 % |
2026-11-17 |
|
Enveric Biosciences Inc
|
ENVB |
US |
1,41 |
USD |
-75,1 % |
2026-11-17 |
|
Equillium Inc
|
EQ |
US |
1,21 |
USD |
+21,0 % |
2026-11-17 |
|
Erasca Inc
|
ERAS |
US |
13,89 |
USD |
+385,7 % |
2026-11-17 |
|
Esperion Therapeutics Inc
|
ESPR |
US |
3,18 |
USD |
— |
2026-07-13 |
|
Eton Pharmaceuticals Inc
|
ETON |
US |
63,65 |
USD |
+270,1 % |
2026-11-17 |
|
Evotec SE
|
EVO |
DE |
1,48 |
EUR |
-50,0 % |
2026-11-17 |
|
Exicure Inc
|
XCUR |
US |
1,02 |
USD |
-72,6 % |
2026-11-17 |
|
FibroGen, Inc - Common Stock
|
FGEN |
— |
— |
USD |
— |
|
|
First Tracks Biotherapeutics
|
TRAX.US |
— |
46,56 |
USD |
— |
2026-11-16 |
|
FitLife Brands Inc
|
FTLF |
US |
6,83 |
USD |
-62,6 % |
2026-11-17 |
|
Foghorn Therapeutics Inc
|
FHTX |
US |
1,83 |
USD |
-63,5 % |
2026-11-17 |
|
Forte Biosciences Inc
|
FBRX |
US |
76,99 |
USD |
+328,4 % |
2026-08-28 |
|
Fortress Biotech Inc
|
FBIO |
US |
1,82 |
USD |
-31,8 % |
2026-11-17 |
|
Fulcrum Therapeutics Inc
|
FULC |
US |
3,75 |
USD |
-61,5 % |
2026-11-17 |
|
Gain Therapeutics Inc
|
GANX |
US |
1,18 |
USD |
-58,6 % |
2026-11-17 |
|
Galectin Therapeutics Inc
|
GALT |
US |
2,91 |
USD |
-53,0 % |
2026-11-17 |
|
Galmed Pharmaceuticals Ltd
|
GLMD |
IL |
3,62 |
USD |
+232,1 % |
2026-10-08 |
|
Gelteq Ltd
|
GELS |
AU |
0,27 |
AUD |
-72,3 % |
2026-11-17 |
|
Genelux Corp
|
GNLX |
US |
2,00 |
USD |
-60,5 % |
2026-11-17 |
|
Generate Biomedicines Inc
|
GENB.US |
— |
9,84 |
USD |
— |
2026-11-17 |
|
Genmab A/S
|
GMAB |
DK |
51,96 |
USD |
+71,4 % |
2026-11-17 |
|
Genprex Inc
|
GNPX |
US |
1,67 |
USD |
-97,9 % |
2026-11-17 |
|
GeoVax Labs Inc
|
GOVX |
US |
2,02 |
USD |
-80,2 % |
2026-11-16 |
|
Geron Corp
|
GERN |
US |
1,00 |
USD |
-9,9 % |
2026-11-17 |
|
GH Research PLC
|
GHRS |
IE |
18,27 |
USD |
+32,9 % |
2026-11-17 |
|
Gossamer Bio Inc
|
GOSS |
US |
10,98 |
USD |
-95,5 % |
2026-11-16 |
|
Greenwich Lifesciences Inc
|
GLSI |
US |
18,70 |
USD |
+126,9 % |
2026-11-17 |
|
GRI Bio Inc
|
GRI |
US |
1,35 |
USD |
-97,3 % |
2026-11-17 |
|
Grifols SA
|
GRFS |
ES |
8,63 |
EUR |
+0,3 % |
2026-11-17 |
|
GSK plc
|
GSK |
GB |
49,24 |
GBP |
+3,9 % |
2026-11-17 |
|
Gyre Therapeutics Inc
|
GYRE |
US |
4,56 |
USD |
-40,5 % |
2026-11-17 |
|
Harmony Biosciences Holdings Inc
|
HRMY |
US |
33,01 |
USD |
-2,9 % |
2026-11-17 |
|
Harrow Inc
|
HROW |
US |
29,52 |
USD |
-25,7 % |
2026-11-17 |
|
HCW Biologics Inc
|
HCWB |
US |
0,78 |
USD |
-94,6 % |
2026-11-17 |
|
Heron Therapeutics Inc
|
HRTX |
US |
0,28 |
USD |
-75,0 % |
2026-11-17 |
|
HUTCHMED (China) Ltd
|
HCM |
HK |
14,40 |
USD |
-1,8 % |
2026-11-17 |
|
iBio Inc
|
IBIO |
US |
0,75 |
USD |
-38,0 % |
2026-11-17 |
|
IDEAYA Biosciences Inc
|
IDYA |
US |
27,40 |
USD |
-18,7 % |
2026-11-17 |
|
Immix Biopharma Inc
|
IMMX |
US |
7,20 |
USD |
+69,4 % |
2026-11-17 |
|
Immuneering Corp
|
IMRX |
US |
3,46 |
USD |
-51,6 % |
2026-11-17 |
|
Immunic Inc
|
IMUX |
US |
7,33 |
USD |
-3,6 % |
2026-11-17 |
|
Immunome Inc
|
IMNM |
US |
17,18 |
USD |
-3,8 % |
2026-11-17 |
|
Immutep Ltd
|
IMMP |
AU |
3,26 |
AUD |
+86,3 % |
2026-11-17 |
|
Impact Biomedical Inc
|
IBO |
US |
6,17 |
USD |
+10,5 % |
2026-11-17 |
|
Imunon Inc
|
IMNN |
US |
0,61 |
USD |
-85,1 % |
2026-11-17 |
|
Incannex Healthcare Inc
|
IXHL |
AU |
1,74 |
USD |
-83,4 % |
2026-11-17 |
|
Indivior PLC
|
INDV |
GB |
36,28 |
USD |
+12,5 % |
2026-11-02 |
|
InflaRx NV
|
IFRX |
DE |
1,15 |
EUR |
-9,4 % |
2026-11-17 |
|
InMed Pharmaceuticals Inc
|
INM |
CA |
17,50 |
USD |
+1 098,6 % |
2026-11-17 |
|
Innoviva Inc
|
INVA |
US |
18,30 |
USD |
-16,3 % |
2026-11-17 |
|
Inovio Pharmaceuticals Inc
|
INO |
US |
1,63 |
USD |
-13,8 % |
2026-11-17 |
|
Insmed Inc
|
INSM |
US |
121,86 |
USD |
-39,6 % |
2026-11-17 |
|
Inventiva SA
|
IVA |
FR |
3,22 |
EUR |
-23,0 % |
2026-11-17 |
|
Ionis Pharmaceuticals Inc
|
IONS |
US |
26,96 |
USD |
-63,8 % |
2026-11-17 |
|
Ironwood Pharmaceuticals Inc
|
IRWD |
US |
4,87 |
USD |
+56,6 % |
2026-11-17 |
|
Jaguar Health Inc
|
JAGX |
US |
0,38 |
USD |
-100,0 % |
2026-11-17 |
|
Janux Therapeutics Inc
|
JANX |
US |
10,71 |
USD |
-63,1 % |
2026-11-17 |
|
Jazz Pharmaceuticals PLC
|
JAZZ |
IE |
240,71 |
USD |
+33,3 % |
2026-11-17 |
|
Johnson & Johnson
|
JNJ |
US |
278,70 |
USD |
+39,3 % |
2026-11-17 |
|
Journey Medical Corp
|
DERM |
US |
3,90 |
USD |
-50,9 % |
2026-11-17 |
|
KALA BIO Inc
|
KALA |
US |
3,43 |
USD |
-90,0 % |
2026-11-17 |
|
Kamada Ltd
|
KMDA |
IL |
8,22 |
USD |
+20,2 % |
2026-11-17 |
|
Karyopharm Therapeutics Inc
|
KPTI |
US |
0,03 |
USD |
-99,5 % |
2026-11-16 |
|
Kazia Therapeutics Ltd
|
KZIA |
AU |
5,62 |
AUD |
-2,4 % |
2026-11-17 |
|
Keros Therapeutics Inc
|
KROS |
US |
10,56 |
USD |
-39,9 % |
2026-11-17 |
|
Kiniksa Pharmaceuticals International PLC
|
KNSA |
GB |
94,87 |
USD |
+129,8 % |
2026-11-17 |
|
Korro Bio Inc
|
KRRO |
US |
12,64 |
USD |
+103,2 % |
2026-11-17 |
|
Kura Oncology Inc
|
KURA |
US |
7,50 |
USD |
-32,4 % |
2026-11-17 |
|
Kyntra Bio Inc
|
KYNB.US |
— |
2,04 |
USD |
-76,3 % |
2026-11-17 |
|
Lantern Pharma Inc
|
LTRN |
US |
0,40 |
USD |
-87,7 % |
2026-11-17 |
|
Lantheus Holdings Inc
|
LNTH |
US |
101,72 |
USD |
+90,1 % |
2026-11-17 |
|
Larimar Therapeutics Inc
|
LRMR |
US |
3,03 |
USD |
-10,6 % |
2026-11-17 |
|
Legend Biotech Corp
|
LEGN |
US |
16,00 |
USD |
-45,6 % |
2026-11-17 |
|
Lexaria Bioscience Corp
|
LEXX |
CA |
4,13 |
USD |
-73,8 % |
2026-11-17 |
|
Lifecore Biomedical Inc
|
LFCR |
US |
6,42 |
USD |
-15,5 % |
2026-11-17 |
|
LifeVantage Corp
|
LFVN |
US |
4,96 |
USD |
-23,5 % |
2026-11-17 |
|
Ligand Pharmaceuticals Inc
|
LGND |
US |
300,48 |
USD |
+45,1 % |
2026-11-17 |
|
Liquidia Corp
|
LQDA |
US |
55,61 |
USD |
+84,1 % |
2026-11-17 |
|
Longeveron Inc
|
LGVN |
US |
2,12 |
USD |
-66,9 % |
2026-11-17 |
|
Lyell Immunopharma Inc
|
LYEL |
US |
13,75 |
USD |
-23,3 % |
2026-11-17 |
|
MacroGenics Inc
|
MGNX |
US |
2,08 |
USD |
+35,1 % |
2026-11-17 |
|
Madrigal Pharmaceuticals Inc
|
MDGL |
US |
420,11 |
USD |
-24,8 % |
2026-11-17 |
|
MannKind Corp
|
MNKD |
US |
4,05 |
USD |
-20,0 % |
2026-11-17 |
|
Maravai LifeSciences Holdings Inc
|
MRVI |
US |
7,33 |
USD |
+102,5 % |
2026-11-17 |
|
Marker Therapeutics Inc
|
MRKR |
US |
0,87 |
USD |
-13,9 % |
2026-11-17 |
|
MBX Biosciences Inc
|
MBX |
US |
51,99 |
USD |
+97,2 % |
2026-11-17 |
|
Medicus Pharma Ltd
|
MDCX |
US |
1,73 |
USD |
-19,4 % |
2026-11-17 |
|
Mediwound Ltd
|
MDWD |
IL |
13,80 |
USD |
-24,5 % |
2026-11-17 |
|
Merck & Co Inc
|
MRK |
US |
144,45 |
USD |
+49,8 % |
2026-11-17 |
|
Mereo BioPharma Group PLC
|
MREO |
GB |
0,28 |
USD |
-84,4 % |
2026-11-17 |
|
MetaVia Inc
|
MTVA |
US |
1,25 |
USD |
-86,0 % |
2026-11-17 |
|
Milestone Pharmaceuticals Inc
|
MIST |
CA |
0,44 |
USD |
-81,8 % |
2026-11-17 |
|
Mind Medicine (MindMed) Inc. - Common Shares
|
MNMD |
— |
— |
USD |
— |
|
|
Mineralys Therapeutics Inc
|
MLYS |
US |
14,55 |
USD |
-66,5 % |
2026-11-17 |
|
MIRA Pharmaceuticals Inc
|
MIRA |
US |
0,62 |
USD |
-56,0 % |
2026-11-17 |
|
Mirum Pharmaceuticals Inc
|
MIRM |
US |
90,40 |
USD |
+25,2 % |
2026-11-17 |
|
Moleculin Biotech Inc
|
MBRX |
US |
7,05 |
USD |
-32,9 % |
2026-11-17 |
|
Monopar Therapeutics Inc
|
MNPR |
US |
70,40 |
USD |
-12,7 % |
2026-11-17 |
|
MoonLake Immunotherapeutics
|
MLTX |
CH |
11,56 |
USD |
-13,7 % |
2026-11-17 |
|
Mustang Bio Inc
|
MBIO |
US |
0,40 |
USD |
-67,1 % |
2026-11-17 |
|
Natural Alternatives International Inc
|
NAII |
US |
0,97 |
USD |
-68,3 % |
2026-11-16 |
|
Nature's Sunshine Products Inc
|
NATR |
US |
10,46 |
USD |
-49,8 % |
2026-11-17 |
|
Nektar Therapeutics
|
NKTR |
US |
35,74 |
USD |
-39,6 % |
2026-11-17 |
|
Neuphoria Therapeutics Inc
|
NEUP |
US |
2,42 |
USD |
-48,9 % |
2026-11-17 |
|
Neurogene Inc
|
NGNE |
US |
22,77 |
USD |
+6,6 % |
2026-11-17 |
|
Neurosense Therapeutics Ltd
|
NRSN |
IL |
1,57 |
USD |
-93,7 % |
2026-11-16 |
|
NewAmsterdam Pharma Company NV
|
NAMS |
NL |
19,35 |
USD |
-50,3 % |
2026-11-17 |
|
NextCure Inc
|
NXTC |
US |
6,79 |
USD |
-32,1 % |
2026-11-17 |
|
Niagen Bioscience Inc
|
NAGE |
US |
1,99 |
USD |
-71,1 % |
2026-11-17 |
|
Nkarta Inc
|
NKTX |
US |
1,20 |
USD |
-33,7 % |
2026-11-17 |
|
Novartis AG
|
NVS |
CH |
159,17 |
USD |
+24,3 % |
2026-11-17 |
|
Novo Nordisk A/S
|
NVO |
DK |
40,41 |
DKK |
-15,0 % |
2026-11-17 |
|
NRX Pharmaceuticals Inc
|
NRXP |
US |
2,34 |
USD |
+2,7 % |
2026-11-17 |
|
NuCana PLC
|
NCNA |
GB |
0,91 |
GBP |
-72,4 % |
2026-11-17 |
|
Nurix Therapeutics Inc
|
NRIX |
US |
14,31 |
USD |
+12,9 % |
2026-11-17 |
|
Nuvation Bio Inc
|
NUVB |
US |
3,83 |
USD |
-20,3 % |
2026-11-17 |
|
Nuvectis Pharma Inc
|
NVCT |
US |
19,00 |
USD |
+214,0 % |
2026-11-17 |
|
Ocular Therapeutix Inc
|
OCUL |
US |
5,97 |
USD |
-49,2 % |
2026-11-17 |
|
Oculis Holding AG
|
OCS |
CH |
7,16 |
CHF |
-62,9 % |
2026-11-17 |
|
Olema Pharmaceuticals Inc
|
OLMA |
US |
7,11 |
USD |
-64,7 % |
2026-11-17 |
|
Omeros Corp
|
OMER |
US |
13,09 |
USD |
+54,0 % |
2026-11-17 |
|
Onconetix Inc
|
ONCO |
US |
2,92 |
USD |
-97,7 % |
2026-11-17 |
|
OPKO Health Inc
|
OPK |
US |
1,60 |
USD |
+25,0 % |
2026-11-17 |
|
Opus Genetics Inc
|
IRD |
US |
4,05 |
USD |
+115,4 % |
2026-11-17 |
|
Oramed Pharmaceuticals Inc
|
ORMP |
US |
3,95 |
USD |
+58,6 % |
2026-11-17 |
|
Organigram Global Inc
|
OGI |
CA |
0,72 |
CAD |
-53,6 % |
2026-11-17 |
|
Organogenesis Holdings Inc
|
ORGO |
US |
0,80 |
USD |
-85,6 % |
2026-11-17 |
|
Organon & Co
|
OGN |
US |
13,90 |
USD |
+80,3 % |
2026-11-17 |
|
Oric Pharmaceuticals Inc
|
ORIC |
US |
7,79 |
USD |
-34,5 % |
2026-11-17 |
|
Oruka Therapeutics Inc
|
ORKA |
US |
96,73 |
USD |
+252,4 % |
2026-11-17 |
|
Ovid Therapeutics Inc
|
OVID |
US |
2,23 |
USD |
+69,2 % |
2026-11-17 |
|
Pacira Biosciences Inc
|
PCRX |
US |
36,48 |
USD |
+49,6 % |
2026-11-16 |
|
Palatin Technologies Inc
|
PTN |
US |
5,36 |
USD |
-60,5 % |
2026-11-17 |
|
Palvella Therapeutics Inc
|
PVLA |
US |
141,24 |
USD |
+70,3 % |
2026-11-17 |
|
Pasithea Therapeutics Corp
|
KTTA |
US |
0,50 |
USD |
-24,2 % |
2026-11-17 |
|
PDS Biotechnology Corp
|
PDSB |
US |
0,94 |
USD |
+19,6 % |
2026-11-17 |
|
PepGen Inc
|
PEPG |
US |
3,78 |
USD |
-34,2 % |
2026-11-17 |
|
Perrigo Company PLC
|
PRGO |
IE |
16,07 |
USD |
+20,0 % |
2026-11-17 |
|
Perspective Therapeutics Inc
|
CATX |
US |
0,86 |
USD |
-62,3 % |
2026-11-17 |
|
Pfizer Inc
|
PFE |
US |
28,56 |
USD |
+12,2 % |
2026-11-17 |
|
Pharvaris NV
|
PHVS |
NL |
31,68 |
EUR |
+32,1 % |
2026-11-17 |
|
Phathom Pharmaceuticals Inc
|
PHAT |
US |
5,70 |
USD |
-62,0 % |
2026-11-17 |
|
Phibro Animal Health Corp
|
PAHC |
US |
34,33 |
USD |
-20,9 % |
2026-11-17 |
|
Phio Pharmaceuticals Corp
|
PHIO |
US |
0,73 |
USD |
-42,8 % |
2026-11-17 |
|
Pliant Therapeutics Inc
|
PLRX |
US |
0,68 |
USD |
-56,9 % |
2026-11-17 |
|
Plus Therapeutics Inc
|
PSTV |
US |
3,84 |
USD |
+652,5 % |
2026-08-07 |
|
PMGC Holdings Inc
|
ELAB |
US |
1,48 |
USD |
-99,9 % |
2026-11-17 |
|
PMV Pharmaceuticals Inc
|
PMVP |
US |
1,08 |
USD |
-23,2 % |
2026-11-17 |
|
Praxis Precision Medicines Inc
|
PRAX |
US |
309,49 |
USD |
+68,1 % |
2026-11-17 |
|
Precigen Inc
|
PGEN |
US |
4,28 |
USD |
-11,9 % |
2026-11-17 |
|
Prelude Therapeutics Inc
|
PRLD |
US |
3,33 |
USD |
+98,2 % |
2026-11-17 |
|
Prestige Consumer Healthcare Inc
|
PBH |
US |
48,03 |
USD |
-18,8 % |
2026-11-17 |
|
PROC
|
PROC |
— |
53,00 |
— |
+73,8 % |
2026-11-17 |
|
Processa Pharmaceuticals Inc
|
PCSA |
US |
1,71 |
USD |
-77,6 % |
2026-11-17 |
|
Prophase Labs Inc
|
PRPH |
US |
0,00 |
USD |
-99,8 % |
2026-11-17 |
|
ProQR Therapeutics NV
|
PRQR |
NL |
1,14 |
EUR |
-45,2 % |
2026-11-17 |
|
Protagenic Therapeutics Inc
|
PTIX |
US |
0,45 |
USD |
-79,5 % |
2026-11-16 |
|
Protagonist Therapeutics Inc
|
PTGX |
US |
122,83 |
USD |
+45,6 % |
2026-11-17 |
|
Prothena Corporation PLC
|
PRTA |
IE |
7,95 |
USD |
-23,3 % |
2026-11-17 |
|
PTC Therapeutics Inc
|
PTCT |
US |
59,25 |
USD |
-22,7 % |
2026-11-17 |
|
Pulmatrix Inc
|
PULM |
US |
1,33 |
USD |
-70,6 % |
2026-11-17 |
|
Puma Biotechnology Inc
|
PBYI |
US |
7,05 |
USD |
+39,3 % |
2026-11-17 |
|
Pyxis Oncology Inc
|
PYXS |
US |
1,36 |
USD |
-71,2 % |
2026-11-17 |
|
Q32 Bio Inc
|
QTTB |
US |
8,57 |
USD |
+275,9 % |
2026-11-17 |
|
Quantum Biopharma Ltd
|
QNTM |
CA |
1,49 |
USD |
-78,1 % |
2026-11-17 |
|
Quoin Pharmaceuticals Ltd
|
QNRX |
IL |
3,54 |
USD |
-81,6 % |
2026-11-17 |
|
Radiopharm Theranostics Ltd
|
RADX |
AU |
0,66 |
AUD |
-84,7 % |
2026-11-17 |
|
Rani Therapeutics Holdings Inc
|
RANI |
US |
0,57 |
USD |
-69,6 % |
2026-11-17 |
|
Rapport Therapeutics Inc
|
RAPP |
US |
23,74 |
USD |
-6,2 % |
2026-11-17 |
|
Redhill Biopharma Ltd
|
RDHL |
IL |
0,36 |
USD |
-66,1 % |
2026-11-17 |
|
Regencell Bioscience Holdings Ltd
|
RGC |
HK |
4,43 |
USD |
-66,2 % |
2026-11-17 |
|
Regeneron Pharmaceuticals Inc
|
REGN |
US |
952,12 |
USD |
+31,3 % |
2026-11-17 |
|
Rein Therapeutics Inc
|
RNTX |
US |
0,37 |
USD |
-69,6 % |
2026-11-17 |
|
Relmada Therapeutics Inc
|
RLMD |
US |
3,17 |
USD |
-25,8 % |
2026-11-17 |
|
RenovoRx Inc
|
RNXT |
US |
1,02 |
USD |
+30,4 % |
2026-11-17 |
|
Revelation Biosciences Inc
|
REVB |
US |
3,95 |
USD |
+14,8 % |
2026-11-17 |
|
Revium Rx
|
RVRC |
IL |
1,43 |
USD |
+175,0 % |
2026-11-16 |
|
Reviva Pharmaceuticals Holdings Inc
|
RVPH |
US |
0,31 |
USD |
-97,1 % |
2026-11-17 |
|
Rezolute Inc
|
RZLT |
US |
3,68 |
USD |
-63,8 % |
2026-11-17 |
|
Rhythm Pharmaceuticals Inc
|
RYTM |
US |
105,46 |
USD |
+4,9 % |
2026-11-17 |
|
Rigel Pharmaceuticals Inc
|
RIGL |
US |
42,50 |
USD |
-8,0 % |
2026-11-17 |
|
Rocket Pharmaceuticals Inc
|
RCKT |
US |
2,06 |
USD |
-29,9 % |
2026-11-17 |
|
Rockwell Medical Inc
|
RMTI |
US |
6,75 |
USD |
-23,3 % |
2026-11-17 |
|
Roivant Sciences Ltd
|
ROIV |
GB |
37,86 |
USD |
+84,5 % |
2026-11-17 |
|
Royalty Pharma PLC
|
RPRX |
US |
67,89 |
USD |
+72,0 % |
2026-11-17 |
|
Sagimet Biosciences Inc
|
SGMT |
US |
9,90 |
USD |
+26,5 % |
2026-11-17 |
|
Sanofi SA
|
SNY |
FR |
47,87 |
EUR |
-5,5 % |
2026-11-17 |
|
Sarepta Therapeutics Inc
|
SRPT |
US |
14,93 |
USD |
-14,4 % |
2026-11-17 |
|
Savara Inc
|
SVRA |
US |
4,43 |
USD |
+6,1 % |
2026-11-17 |
|
Schrodinger Inc
|
SDGR |
US |
25,95 |
USD |
+52,6 % |
2026-11-17 |
|
Scienture Holdings Inc
|
SCNX |
US |
2,76 |
USD |
+339,5 % |
2026-11-17 |
|
SCYNEXIS Inc
|
SCYX |
US |
2,85 |
USD |
-38,6 % |
2026-11-17 |
|
SELB
|
SELB |
— |
— |
— |
— |
|
|
Sellas Life Sciences Group Inc
|
SLS |
US |
19,99 |
USD |
+1 157,5 % |
2026-11-17 |
|
Septerna Inc
|
SEPN |
US |
39,89 |
USD |
+83,9 % |
2026-11-17 |
|
Seres Therapeutics Inc
|
MCRB |
US |
1,38 |
USD |
-94,4 % |
2026-11-17 |
|
Shattuck Labs Inc
|
STTK |
US |
4,52 |
USD |
+124,9 % |
2026-11-17 |
|
Shuttle Pharmaceuticals Holdings Inc
|
SHPH |
US |
4,22 |
USD |
-80,0 % |
2026-11-17 |
|
SIGA Technologies Inc
|
SIGA |
US |
2,82 |
USD |
-52,8 % |
2026-11-17 |
|
Silence Therapeutics PLC
|
SLN |
GB |
19,80 |
USD |
+193,3 % |
2026-11-17 |
|
Silo Pharma Inc
|
SILO |
US |
1,63 |
USD |
-74,1 % |
2026-11-17 |
|
Sionna Therapeutics Inc
|
SION |
US |
3,06 |
USD |
-92,2 % |
2026-11-17 |
|
Skye Bioscience Inc
|
SKYE |
US |
1,09 |
USD |
-89,8 % |
2026-11-17 |
|
SNDL Inc
|
SNDL |
CA |
1,35 |
CAD |
-19,9 % |
2026-11-17 |
|
Sol Gel Technologies Ltd
|
SLGL |
IL |
54,07 |
USD |
+52,7 % |
2026-11-17 |
|
Soligenix Inc
|
SNGX |
US |
0,28 |
USD |
-79,3 % |
2026-11-17 |
|
Spero Therapeutics Inc
|
SPRO |
US |
0,89 |
USD |
-64,0 % |
2026-11-17 |
|
Spyre Therapeutics Inc
|
SYRE |
US |
94,82 |
USD |
+293,4 % |
2026-11-17 |
|
Standard BioTools Inc
|
LAB |
US |
0,61 |
USD |
-50,5 % |
2026-11-17 |
|
Stoke Therapeutics Inc
|
STOK |
US |
26,61 |
USD |
-8,0 % |
2026-11-17 |
|
Structure Therapeutics Inc
|
GPCR |
US |
18,57 |
USD |
-46,2 % |
2026-11-16 |
|
Summit Therapeutics Inc
|
SMMT |
US |
10,95 |
USD |
-34,9 % |
2026-11-17 |
|
Sunshine Biopharma Inc
|
SBFM |
US |
2,51 |
USD |
-83,2 % |
2026-11-17 |
|
Supernus Pharmaceuticals Inc
|
SUPN |
US |
29,20 |
USD |
-35,0 % |
2026-11-17 |
|
Syndax Pharmaceuticals Inc
|
SNDX |
US |
9,34 |
USD |
-45,4 % |
2026-11-17 |
|
Synergy CHC Corp
|
SNYR |
US |
0,00 |
USD |
-100,0 % |
2026-11-16 |
|
Takeda Pharmaceutical Co Ltd
|
TAK |
JP |
21,72 |
JPY |
+54,3 % |
2026-11-17 |
|
Tango Therapeutics Inc
|
TNGX |
US |
22,54 |
USD |
+181,8 % |
2026-11-17 |
|
Telix Pharmaceuticals Limited - American Depositary Shares
|
TLX |
US |
8,90 |
USD |
-3,0 % |
2026-11-17 |
|
Telomir Pharmaceuticals Inc
|
TELO |
US |
0,42 |
USD |
-70,6 % |
2026-11-17 |
|
Tempest Therapeutics Inc
|
TPST |
US |
0,31 |
USD |
-96,6 % |
2026-11-17 |
|
Tenax Therapeutics Inc
|
TENX |
US |
1,46 |
USD |
-81,0 % |
2026-11-17 |
|
Teva Pharmaceutical Industries Ltd
|
TEVA |
IL |
42,22 |
USD |
+70,0 % |
2026-11-17 |
|
TG Therapeutics Inc
|
TGTX |
US |
63,01 |
USD |
+101,9 % |
2026-11-17 |
|
Theravance Biopharma Inc
|
TBPH |
KY |
17,03 |
USD |
-7,9 % |
2026-09-25 |
|
Tilray Brands Inc
|
TLRY |
CA |
2,36 |
USD |
-77,1 % |
2026-11-17 |
|
Tiziana Life Sciences Ltd
|
TLSA |
GB |
0,68 |
USD |
-61,5 % |
2026-11-17 |
|
Tonix Pharmaceuticals Holding Corp
|
TNXP |
US |
2,95 |
USD |
-81,9 % |
2026-11-17 |
|
Transcode Therapeutics Inc
|
RNAZ |
US |
1,30 |
USD |
-85,6 % |
2026-11-17 |
|
Travere Therapeutics Inc
|
TVTX |
US |
50,38 |
USD |
+39,9 % |
2026-11-17 |
|
Traws Pharma Inc
|
TRAW |
US |
0,24 |
USD |
-88,8 % |
2026-11-17 |
|
Trevi Therapeutics Inc
|
TRVI |
US |
13,17 |
USD |
+16,4 % |
2026-11-17 |
|
TuHURA Biosciences Inc
|
HURA |
US |
1,40 |
USD |
-27,5 % |
2026-11-17 |
|
Tyra Biosciences Inc
|
TYRA |
US |
19,74 |
USD |
+23,1 % |
2026-11-17 |
|
Ultragenyx Pharmaceutical Inc
|
RARE |
US |
16,18 |
USD |
-50,7 % |
2026-11-17 |
|
Unicycive Therapeutics Inc
|
UNCY |
US |
3,69 |
USD |
-37,7 % |
2026-11-17 |
|
Uniqure NV
|
QURE |
NL |
20,76 |
USD |
-30,1 % |
2026-11-17 |
|
United Therapeutics Corp
|
UTHR |
US |
578,09 |
USD |
+21,3 % |
2026-11-17 |
|
Universe Pharmaceuticals Inc
|
UPC |
CN |
1,52 |
USD |
-57,4 % |
2026-11-17 |
|
Upstream Bio Inc
|
UPB |
US |
2,07 |
USD |
-91,9 % |
2026-11-17 |
|
Urogen Pharma Ltd
|
URGN |
IL |
29,01 |
USD |
+23,2 % |
2026-11-17 |
|
USANA Health Sciences Inc
|
USNA |
US |
13,68 |
USD |
-27,1 % |
2026-11-17 |
|
Vanda Pharmaceuticals Inc
|
VNDA |
US |
3,83 |
USD |
-28,5 % |
2026-11-17 |
|
Vera Therapeutics Inc
|
VERA |
US |
26,00 |
USD |
-10,1 % |
2026-11-17 |
|
Veradermics Inc
|
MANE.US |
— |
125,64 |
USD |
— |
2026-11-17 |
|
Verrica Pharmaceuticals Inc
|
VRCA |
US |
2,93 |
USD |
-23,5 % |
2026-11-17 |
|
Vertex Pharmaceuticals Inc
|
VRTX |
US |
535,74 |
USD |
+23,0 % |
2026-11-17 |
|
Vertex Pharmaceuticals Inc
|
VX1 |
EU |
487,00 |
EUR |
+29,4 % |
2026-11-17 |
|
Veru Inc
|
VERU |
US |
2,17 |
USD |
-14,2 % |
2026-11-17 |
|
Viatris Inc
|
VTRS |
US |
20,61 |
USD |
+92,4 % |
2026-11-17 |
|
Viking Therapeutics Inc
|
VKTX |
US |
27,06 |
USD |
-28,4 % |
2026-11-17 |
|
Viridian Therapeutics Inc
|
VRDN |
US |
29,63 |
USD |
+3,6 % |
2026-11-17 |
|
Vistagen Therapeutics Inc
|
VTGN |
US |
0,18 |
USD |
-96,0 % |
2026-11-17 |
|
VYNE Therapeutics Inc. - Common Stock
|
VYNE |
— |
28,56 |
USD |
— |
2026-07-27 |
|
WAVE Life Sciences Ltd
|
WVE |
SG |
2,90 |
USD |
-59,2 % |
2026-11-17 |
|
Werewolf Therapeutics Inc
|
HOWL |
US |
1,05 |
USD |
+14,8 % |
2026-11-17 |
|
Whitehawk Therapeutics Inc
|
WHWK |
US |
3,06 |
USD |
+42,8 % |
2026-11-17 |
|
XBiotech Inc
|
XBIT |
US |
1,78 |
USD |
-24,3 % |
2026-11-17 |
|
Xencor Inc
|
XNCR |
US |
34,76 |
USD |
+117,0 % |
2026-11-17 |
|
Xenon Pharmaceuticals Inc
|
XENE |
CA |
38,67 |
USD |
-4,8 % |
2026-11-17 |
|
Xeris Biopharma Holdings Inc
|
XERS |
US |
16,86 |
USD |
+138,1 % |
2026-11-17 |
|
Xilio Therapeutics Inc
|
XLO |
US |
7,84 |
USD |
-25,4 % |
2026-11-17 |
|
Zai Lab Ltd
|
ZLAB |
CN |
23,53 |
USD |
+14,9 % |
2026-11-17 |
|
Zenas Biopharma Inc
|
ZBIO |
US |
27,75 |
USD |
-23,4 % |
2026-11-17 |
|
Zentalis Pharmaceuticals Inc
|
ZNTL |
US |
1,50 |
USD |
+10,3 % |
2026-11-17 |
|
Zevra Therapeutics Inc
|
ZVRA |
US |
9,25 |
USD |
-4,6 % |
2026-11-17 |
|
Zhengye Biotechnology Holding Ltd
|
ZYBT |
CN |
1,45 |
CNY |
-31,9 % |
2026-11-17 |
|
Zoetis Inc
|
ZTS |
US |
83,52 |
USD |
-29,3 % |
2026-11-17 |
|
Zymeworks Inc
|
ZYME |
US |
25,97 |
USD |
+12,9 % |
2026-11-17 |
|
Zyversa Therapeutics Inc
|
ZVSA |
US |
0,00 |
USD |
-99,9 % |
2026-11-13 |